1. Home
  2. CVSA vs STVN Comparison

CVSA vs STVN Comparison

Compare CVSA & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Covista Inc. Common Shares

CVSA

Covista Inc. Common Shares

N/A

Current Price

$131.39

Market Cap

4.3B

Sector

Real Estate

ML Signal

N/A

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$19.89

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVSA
STVN
Founded
1987
1949
Country
United States
Italy
Employees
4996
N/A
Industry
Other Consumer Services
Containers/Packaging
Sector
Real Estate
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.7B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CVSA
STVN
Price
$131.39
$19.89
Analyst Decision
Strong Buy
Buy
Analyst Count
2
3
Target Price
$150.00
$25.67
AVG Volume (30 Days)
324.4K
323.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
0.39%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.66
$9.67
Revenue Next Year
$6.58
$9.99
P/E Ratio
N/A
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$96.08
$12.89
52 Week High
$135.96
$28.00

Technical Indicators

Market Signals
Indicator
CVSA
STVN
Relative Strength Index (RSI) 58.33 64.32
Support Level $115.79 $13.58
Resistance Level $132.60 $22.00
Average True Range (ATR) 4.82 0.79
MACD 0.58 0.18
Stochastic Oscillator 73.44 84.23

Price Performance

Historical Comparison
CVSA
STVN

About CVSA Covista Inc. Common Shares

Covista Inc is an American healthcare educator, serving more than 97,000 students and supported by a community of alumni across five accredited institutions. Through personalized, tech-enabled education powered by faculty and colleagues, it expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: